<p>Human moDC were exposed to 100 nM SFA, CsA, dexamethasone or vehicle. After 4 h moDCs were stimulated with LPS (100 ng/ml) and CCL5, CCL17, CCL19, CXCL9, CXCL10 were analyzed by ELISA after 12 h. In contrast to CsA and dexamethasone, SFA markedly inhibited CCL5 (A), CCL17 (B) and CCL19 expression (C).</p
There is growing interest in the use of tolerogenic dendritic cells (tolDCs) as a potential target f...
<p><b>A</b>, LAD2 human mast cells were treated with fluticasone (1 uM) or salmeterol (1 uM) or in c...
<p>(A) PGE<sub>2</sub> concentration in supernatants from moDC cultures after stimulation with indic...
<p>Human moDC were exposed on day 5 with 10, 50 100, 250 and 500 nM of SFA and 4 hours later stimula...
<p>Human moDCs were generated in the presence of GM-CSF and IL-4. 100 nM SFA or drug vehicle were ad...
<p>Human moDCs were exposed to SFA, CsA or vehicle and matured for 12 h (A) or 24 h (B–D) with LPS (...
<p>To analyze whether DC chemokine suppression by SFA is dependent on cyclophilin A binding competit...
<p>Human moDCs were treated with 1 µM SFA or vehicle for 1 hour and total RNA was prepared after 12 ...
<p>moDCs at day 7 in culture were used for cell phagocytosis and cell differentiation status analysi...
CD14+ monocytes were cultured with 100 ng/ml IL-4, 80 ng/ml GM-CSF ± MDA-MB231-, HeLa-, HT29-, WM278...
<p>Immature human MoDC were incubated with scGOS/lcFOS (5 mg/ml) for 24h. Medium-treated MoDC served...
<p>Human monocyte-derived DCs (MoDCs) were generated by culturing respective precursor cells in the ...
There is growing interest in the use of tolerogenic dendritic cells (tolDCs) as a potential target f...
<p>moDCs were generated in the presence of GM-CSF and IL-4 and activated for 12 h with LPS. CD4 T ce...
<p>ELISA was used to determine the release of cytokines (IL-6, TNF-α, IL-10) and chemokine (IL-8) fr...
There is growing interest in the use of tolerogenic dendritic cells (tolDCs) as a potential target f...
<p><b>A</b>, LAD2 human mast cells were treated with fluticasone (1 uM) or salmeterol (1 uM) or in c...
<p>(A) PGE<sub>2</sub> concentration in supernatants from moDC cultures after stimulation with indic...
<p>Human moDC were exposed on day 5 with 10, 50 100, 250 and 500 nM of SFA and 4 hours later stimula...
<p>Human moDCs were generated in the presence of GM-CSF and IL-4. 100 nM SFA or drug vehicle were ad...
<p>Human moDCs were exposed to SFA, CsA or vehicle and matured for 12 h (A) or 24 h (B–D) with LPS (...
<p>To analyze whether DC chemokine suppression by SFA is dependent on cyclophilin A binding competit...
<p>Human moDCs were treated with 1 µM SFA or vehicle for 1 hour and total RNA was prepared after 12 ...
<p>moDCs at day 7 in culture were used for cell phagocytosis and cell differentiation status analysi...
CD14+ monocytes were cultured with 100 ng/ml IL-4, 80 ng/ml GM-CSF ± MDA-MB231-, HeLa-, HT29-, WM278...
<p>Immature human MoDC were incubated with scGOS/lcFOS (5 mg/ml) for 24h. Medium-treated MoDC served...
<p>Human monocyte-derived DCs (MoDCs) were generated by culturing respective precursor cells in the ...
There is growing interest in the use of tolerogenic dendritic cells (tolDCs) as a potential target f...
<p>moDCs were generated in the presence of GM-CSF and IL-4 and activated for 12 h with LPS. CD4 T ce...
<p>ELISA was used to determine the release of cytokines (IL-6, TNF-α, IL-10) and chemokine (IL-8) fr...
There is growing interest in the use of tolerogenic dendritic cells (tolDCs) as a potential target f...
<p><b>A</b>, LAD2 human mast cells were treated with fluticasone (1 uM) or salmeterol (1 uM) or in c...
<p>(A) PGE<sub>2</sub> concentration in supernatants from moDC cultures after stimulation with indic...